Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Diabetes
Diabetes for September/October 2016
Trends in Drug Utilization Among Patients with T2D, Diabetes Care; ePub 2016 Sep 22; Lipska, et al
FDA Approves Invokamet XR for Treatment of T2D, Janssen Pharmaceuticals news release; 2016 Sep 21
Semaglutide and CV Outcomes in Patients with T2D, N Engl J Med; ePub 2016 Sep 16; Marso, et al
Added Sugars & Risk of CVD in Children, Circulation; ePub 2016 Aug 22; Vos, Kaar, et al
Diabetes for July/August 2016
Sedentary Behavior and Risk of CVD Mortality, Circulation; ePub 2016 Aug 15; Young, Hivert, et al
Bladder Cancer Risk with Pioglitazone in Patients with T2D, BMJ; 2016 ePub Aug 16; Korhonen, Heintjes, et al
Physical Activity and Risk of Multiple Diseases, BMJ; ePub 2016 Aug 9; Kyu, Bachman, et al
Is Chronic Kidney Disease in the US on the Rise?, Ann Intern Med; ePub 2016 Aug 2; Murphy, McCulloch, et al
FDA Approves Adlyxin for Type 2 Diabetes , FDA news release; 2016 Jul 28
Diabetes for May/June 2016
Liraglutide & CV Outcomes in Patients with T2D, N Engl J Med; ePub 2016 Jun 13; Marso, Daniels, et al
Can Empagliflozin Slow Progression of Kidney Disease?, N Engl J Med; ePub 2016 Jun 14; Wanner, Inzucchi, et al
FDA Approves Jentadueto XR Tablets for Adults with T2D, Eli Lilly news release; 2016 May 31
Diagnosis & Management of Diabetes in Primary Care, Ann Intern Med; 2016 Apr 19; Chamberlain, Rhinehart, et al
Diabetes for March/April 2016
Metformin Warning & Labeling Changes, FDA press release; 2016 Apr 4
FDA Adds New Warnings to Diabetes Meds for HF Risk, FDA press release; 2016 Apr 5
Diagnosis & Treatment of Prediabetes in Primary Care, J Am Board Fam Med; 2016 Mar-Apr; Mainous III, Tanner, et al
Insulin Glargine Up-Titration vs Insulin Degludec/Liraglutide, JAMA; 2016 Mar 1; Lingvay, Manghi, et al
Glucose-Lowering Agent Shows CV Benefit, ClinicalTrials.gov; ePub 2016 Mar 4
Diabetes for January/February 2016
FDA Approves Omnigraft for Diabetic Foot Ulcers, New indication for matrix device
PPIs and the Risk of Chronic Kidney Disease, What is the association?
FDA Approves Basaglar for Diabetes, New form of pen-like injector